WallStreetZenWallStreetZen

NASDAQ: JBIO
Jade Biosciences Inc Stock Ownership - Who owns Jade Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Jade Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fairmount Funds Management LLCDirector2025-10-061,333,126$9.14
$12.18MBuy
Tom FrohlichChief Executive Officer2025-05-166,000$7.40
$44.40kBuy

1 of 1

JBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JBIO insiders and whales buy or sell their stock.

JBIO Shareholders

What type of owners hold Jade Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC13.98%6,894,488$95.97MInstitution
Fairmount Funds Management LLC9.23%4,553,494$63.38MInsider
Fairmount Funds Management LLC9.23%4,553,494$63.38MInstitution
Sofinnova Venture Partners X LP7.62%3,758,686$52.32MInsider
Maha Katabi7.62%3,758,686$52.32MInsider
Ra Capital Management LP7.44%3,671,083$51.10MInstitution
Bellevue Group Ag6.77%3,341,103$46.51MInstitution
Vr Adviser LLC6.53%3,220,364$44.83MInstitution
Blackrock Inc5.82%2,870,313$39.95MInstitution
Atlas Venture Fund XII LP4.72%2,327,909$32.40MInsider

1 of 3

JBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JBIO71.10%28.90%Net Buying
ANRO78.47%21.53%Net SellingNet Selling
DBVT9.57%19.90%Net SellingNet Selling
ANNX82.99%17.01%Net BuyingNet Selling
PROK14.28%39.20%Net Buying
View Top Biotech Stocks

Jade Biosciences Stock Ownership FAQ

Who owns Jade Biosciences?

Jade Biosciences (NASDAQ: JBIO) is owned by 95.46% institutional shareholders, 38.79% Jade Biosciences insiders, and 0.00% retail investors. Fairmount Funds Management LLC is the largest individual Jade Biosciences shareholder, owning 4.55M shares representing 9.23% of the company. Fairmount Funds Management LLC's Jade Biosciences shares are currently valued at $63.38M.

If you're new to stock investing, here's how to buy Jade Biosciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.